TGFB1 and myelodysplastic syndrome: In patients with MDS, MSCs also exhibit immunosuppressive function; MDS-MSCs secrete high levels of TGF-β1 (77), a cytokine that exerts significant immunosuppressive effects on B, T, and natural killer (NK) cells, as well as immunostimulatory effects on regulatory T cells (Treg cells).